ACCENDRA HEALTH INC/VA/
Company Stats
- Market Cap
- $43.3M
- as of Sep 30, 2026
- Shares Outstanding
- 76.9M
- Free Float
- 32.2%
Income Statement
- Revenue
- $2.8B
- Operating Income
- $27.5M
- Net Income
- -$1.1B
- EBITDA
- $242.0M
- Revenue Growth, 3Y
- -34.8%
- FCF Margin, 3Y Avg
- 3.8%
- FCF Margin, Worst Year
- -10.6%
Cash Flow
- Free Cash Flow
- -$292.7M
- FCF Yield
- -676.5%
- Owner FCF Yield
- -706.2%
Balance Sheet
- Cash & Equivalents
- $282.0M
Returns & Capital
- Share Repurchases
- $10.2M
- SBC, 3Y Avg
- $14.6M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $2.8B | -$292.7M | -10.6% |
| FY2024 | $2.7B | -$8.8M | -0.3% |
| FY2023 | $2.6B | $568.3M | 22.3% |
| FY2022 | $10.0B | $166.9M | 1.7% |
| FY2021 | $9.8B | $83.2M | 0.9% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 18, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges